AUTHOR=Clerici Bianca , Muscatello Antonio , Bai Francesca , Pavanello Donatella , Orlandi Michela , Marchetti Giulia C. , Castelli Valeria , Casazza Giovanni , Costantino Giorgio , Podda Gian Marco 

TITLE=Sensitivity of SARS-CoV-2 Detection With Nasopharyngeal Swabs

JOURNAL=Frontiers in Public Health

VOLUME=8

YEAR=2021

URL=https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2020.593491

DOI=10.3389/fpubh.2020.593491

ISSN=2296-2565

ABSTRACT=<p><bold>Background:</bold> SARS-CoV-2-infected subjects have been proven contagious in the symptomatic, pre-symptomatic and asymptomatic phase. The identification of these patients is crucial in order to prevent virus circulation. No reliable data on the sensitivity of nasopharyngeal swabs (NPS) are available because of the lack of a shared reference standard to identify SARS-CoV-2 infected patients. The aim of our study was to collect data on patients with a known diagnosis of COVID-19 who underwent serial testing to assess NPS sensitivity.</p><p><bold>Methods:</bold> The study was a multi-center, observational, retrospective clinical study with consecutive enrollment. We enrolled patients who met all of the following inclusion criteria: clinical recovery, documented SARS-CoV-2 infection (≥1 positive rRT-PCR result) and ≥1 positive NPS among the first two follow-up swabs. A positive NPS not preceded by a negative nasopharyngeal swab collected 24–48 h earlier was considered a true positive. A negative NPS followed by a positive NPS collected 24–48 h later was regarded as a false negative. The primary outcome was to define sensitivity of SARS-CoV-2 detection with NPS.</p><p><bold>Results:</bold> Three hundred and ninety three NPS were evaluated in 233 patients; the sensitivity was 77% (95% CI, 73 to 81%). Sensitivity of the first follow-up NPS (<italic>n</italic> = 233) was 79% (95% CI, 73 to 84%) with no significant variations over time. We found no statistically significant differences in the sensitivity of the first follow-up NPS according to time since symptom onset, age, sex, number of comorbidities, and onset symptoms.</p><p><bold>Conclusions:</bold> NPS utility in the diagnostic algorithm of COVID-19 should be reconsidered.</p>